Tài liệu tham khảo |
Loại |
Chi tiết |
1. Riddle MC. Glycemic management of type 2 diabetes: an emerging strategy with oral agents, insulins, and combinations. Endocrinol Metab Clin N Am 2005;34: 77–98 |
Sách, tạp chí |
Tiêu đề: |
Endocrinol"Metab Clin N Am |
|
3. Yki-Jarvinen H. Combination therapies with insulin in type 2 diabetes. Diabetes Care 2001;24: 758–767 4. Inzucchi SE. Oral antihyperglycemic therapy for type 2 diabetes. JAMA 2002;287: 360–372 |
Sách, tạp chí |
Tiêu đề: |
Diabetes Care"2001;24: 758–7674. Inzucchi SE. Oral antihyperglycemic therapy for type 2 diabetes."JAMA |
|
5. Wright A, Burden ACF, Paisey RB, Cull CA, Holman RR, the UK Prospective Diabetes Study Group. Sulfonylurea inadequacy.Efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the UK Prospective Diabetes Study (UKPDS 57) Diabetes Care 2002;25: 330–336 |
Sách, tạp chí |
Tiêu đề: |
Diabetes Care"2002;25: 330"– |
|
6. DeWitt DE, Hirsch IB. Outpatient insulin therapy in type 1 and type 2 diabetes mellitus. JAMA 2003;289: 2254–2264 |
Sách, tạp chí |
|
7. Shichiri M, Kishikawa H, Ohkubo Y, Wake N. Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients. Diabetes Care 2000;23(Suppl 2): B21–B29 |
Sách, tạp chí |
|
8. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998:352: 837–853 |
Sách, tạp chí |
|
9. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998;352: 854–865 |
Sách, tạp chí |
|
10. Riddle MC. Sulfonylureas differ in effects on ischemic preconditioning – Is it time to retire glyburide? J Clin Endocrinol Metab 2003;88; 528–530 |
Sách, tạp chí |
Tiêu đề: |
J Clin Endocrinol Metab |
|
11. Schwartz TB, Meinert CL. The UGDP controversy: thirty-four years of contentious ambiguity laid to rest. Perspect Biol Med 2004;47:564–574 |
Sách, tạp chí |
Tiêu đề: |
Perspect Biol Med |
|
12. Monami M, Luzzi C, Lamanna C, Chiasserini V, Addante F, Desideri CM, Masotti G, Marchionni N, Mannucci E. Three-year mortality in diabetic patients treated with different combinations of insulin secretagogues and metformin. Diabetes/Metabolism Res Rev 2006;22: 477–482 |
Sách, tạp chí |
Tiêu đề: |
Diabetes/Metabolism Res"Rev |
|
13. Chiasson J-L, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M, the STOP-NIDDM Trial Research Group. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance. The STOP-NIDDM Trial. JAMA 2003;290: 486–494 |
Sách, tạp chí |
|